Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 24,030 | 9,155 | 9,140 | 15,377 | 15,346 |
| Cost of Goods | 20,296 | 8,926 | 8,959 | 14,497 | 14,219 |
| Gross Profit | 3,734 | 229 | 181 | 880 | 1,126 |
| Operating Expenses | 1,486 | 416 | 463 | 488 | 436 |
| Operating Income | 2,248 | -187 | -282 | 391 | 691 |
| Other Income | -245 | -106 | 556 | 542 | 107 |
| Pre-tax Income | 2,002 | -293 | 274 | 933 | 798 |
| Income Tax | 722 | -377 | 97 | 403 | 303 |
| Net Income Continuous | 1,280 | 84 | 178 | 530 | 495 |
| Net Income | $1,280 | $84 | $178 | $530 | $495 |
| EPS Basic Total Ops | 0.06 | 0.01 | 0.01 | 0.03 | 0.03 |
| EPS Basic Continuous Ops | 0.06 | 0.01 | 0.01 | 0.03 | 0.03 |
| EPS Diluted Total Ops | 0.06 | 0.01 | 0.01 | 0.03 | 0.03 |
| EPS Diluted Continuous Ops | 0.06 | 0.01 | 0.01 | 0.03 | 0.03 |
| EBITDA(a) | $3,734 | $229 | $181 | $899 | $1,125 |